Kymab
Discovers and develops human antibody therapeutics
Total raised
€109M
€109,454,544
Funding rounds
3
Investors
1
distinct backers
Active since
2010-06
latest 2015-04
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood20
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood24
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €100M+ raised
- ▲ 17y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-05-01 | Series B | €45M | Woodford Investment Management | View deal → |
| 2014-05-01 | Series B | €36M | — | View deal → |
| 2010-07-01 | Series A | €28M | — | View deal → |